Compare AbbVie Inc (ABBV) vs Amazon.com Inc (AMZN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs Amazon.com Inc — how do they compare? AbbVie Inc trades at $254 (market cap $449.91B), while Amazon.com Inc trades at $242.01 (market cap $2.65T). The key difference: Amazon.com Inc is far larger — about 5.9× AbbVie Inc's market cap, and AbbVie Inc pays a 2.72% dividend while Amazon.com Inc pays none. Which is the better fit depends on your goals.
| ABBV | AMZN | |
|---|---|---|
Market Cap | $449.91B | $2.65T |
Sector | Health | Consumer Cyclical |
52-Week High | $261.07 | $274.95 |
52-Week Low | $184.85 | $198.79 |
Enterprise Value | $513.38B | $2.71T |
Dividend Yield | 2.72% | — |
Volume | — | 3,931,282 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $252.92, down 0.72% on the day, with strong technical support at $251 and resistance at $258. The stock shows bullish momentum with recent earnings beats and a consensus analyst price target of $266.33. Revenue grew to $61.16B in 2025, though net margins compressed to 5.79%. Key growth drivers include Skyrizi and Rinvoq offsetting Humira declines, supported by positive Phase 2 data for ELAHERE in ovarian cancer (PRNewsWire, 2026-04-12).
Outlook remains positive with immunology portfolio strength and dividend growth, but risks include patent cliffs in the 2030s and high debt levels. Institutional buying and 68% analyst buy ratings suggest confidence, though valuation multiples like P/E of 124.83 warrant caution. Near-term catalysts include Q2 2026 earnings expected at $3.79 EPS.
Amazon (AMZN) trades at $242.55, down 0.66% on the day, with a bullish technical outlook supported by moving averages. The company reported strong revenue growth to $716.92 billion in 2025, with net income reaching $77.67 billion and a profit margin of 10.83%. Recent news highlights CEO Andy Jassy's optimistic outlook on AWS and AI chip capacity, driving positive sentiment. The stock is near key support at $243, with resistance at $248.
Outlook remains positive with 88.3% analyst buy ratings and a $321.11 consensus price target, implying significant upside. Risks include intense competition in e-commerce and cloud services, high valuation multiples, and macroeconomic pressures. Earnings growth and AI-driven AWS expansion are key catalysts, but investors should monitor execution and capex trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Amazon.com Inc
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →
